Nathan Bahr

Nathan Bahr is an Associate Professor in the Division of Infectious Diseases and International Medicine within the Department of Medicine at the University of Minnesota Medical School. His work focuses on infectious diseases with particular emphasis on fungal infections, tuberculosis, and meningitis in HIV-positive populations and resource-limited settings.

Dr. Bahr's research spans histoplasmosis, cryptococcal meningitis, and tuberculous meningitis with strong expertise in diagnostic test development and treatment optimization. His work integrates clinical epidemiology, biomarker validation, and implementation science in high-HIV burden regions like Uganda, addressing critical gaps in endemic mycoses management and central nervous system infection protocols.

Analysis of his recent publications reveals dominant trends in improving diagnostic accuracy for fungal infections through urinary antigen assays and lateral flow tests, alongside optimizing antifungal induction regimens—particularly single high-dose liposomal amphotericin B for cryptococcal meningitis in sub-Saharan Africa. His work consistently bridges laboratory innovation with real-world clinical application in resource-constrained environments.

Scientific awards and honors include:

• Fellow of the Infectious Diseases Society of America (FIDSA)

Dr. Bahr actively contributes to clinical guideline development through the Infectious Diseases Society of America while maintaining a robust research program focused on reducing mortality from neglected tropical infections through improved diagnostics and accessible therapeutics.